Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yu Nishijima"'
Autor:
Yu Nishijima, Mantaro Hironaka
Publikováno v:
Journal of Insect Behavior. 36:133-141
Autor:
Yu Nishijima, Naotaka Ota
Publikováno v:
Reports of the City Planning Institute of Japan. 19:370-373
Autor:
Seigo Minami, Suguru Yamamoto, Moto Yaga, Taro Koba, Tomoyuki Otsuka, Takeshi Uenami, Masahide Mori, Takashi Kijima, Yu Nishijima-Futami, Shinji Futami, Hiromi Kimura, Hiroyuki Kagawa, Kentaro Masuhiro, Kiyoshi Komuta, Satoshi Kohmo
Publikováno v:
Cancer Chemotherapy and Pharmacology. 82:111-117
We conducted a phase II trial to evaluate the efficacy and safety of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for advanced non-squamous non-small-cell lung cancer (NSCLC). Patients with advance
Autor:
Hidekazu Suzuki, Taro Koba, Masayoshi Higashiguchi, Tomonori Hirashima, Takashi Kijima, Shinji Futami, Kiyoshi Komuta, Seigo Minami, Yu Nishijima-Futami, Motohiro Tamiya
Publikováno v:
Cancer Chemotherapy and Pharmacology. 79:1215-1220
To assess the efficacy and toxicity of S-1 and bevacizumab combination therapy for patients previously treated for advanced non-squamous non-small cell lung cancer (NSCLC). This was a prospective, multi-center, single-arm phase II study. Patients wit
Autor:
Masayoshi Higashiguchi, Shigenori Hoshino, Takashi Kijima, Toshiyuki Minami, Yasushi Shintani, Shin-ichi Nakatsuka, Takayuki Takimoto, Akio Osa, Naoki Hosen, Sujin Kang, Yoshitomo Hayama, Izumi Nagatomo, Yuhei Kinehara, Daisuke Ito, Atsushi Kumanogoh, Kazumi Nishino, Hiroshi Kida, Osamu Morimura, Kota Iwahori, Takeshi Nakatani, Meinoshin Okumura, Hyota Takamatsu, Haruhiko Hirata, Yasuhiro Kato, Yoshito Takeda, Yoshimitsu Nakanishi, Yu Nishijima-Futami, Shohei Koyama, Satoshi Nojima, Fumio Imamura, Yasuhiko Suga, Toru Kumagai, Kotaro Miyake, Masayuki Nishide, Ryota Kurebayashi
Publikováno v:
JCI Insight. 3
Although responses to EGFR tyrosine kinase inhibitors (EGFR-TKIs) are initially positive, 30%-40% of patients with EGFR-mutant tumors do not respond well to EGFR-TKIs, and most lung cancer patients harboring EGFR mutations experience relapse with res
Autor:
Masanori Yoshikawa, Daisy J.A. Janssen, Selina Dürr, Rudolf Joerres, Julia Billington, Nicholas Locantore, Florin Mihaltan, Sally Singh, Dimitar Sajkov, Thys van der Molen, Borja G. Cosío, Guilherme F. da Silva, Sarah Houben-Wilke, Ian Norman, Baykal Tulek, Jose M. Marin, David Miedinger, Samantha Coster, Janwillem W. H. Kocks, Sang Do Lee, Karel Hejduk, Juan P. de Torres, Maria Gonik, Mark Small, Samantha S.C. Kon, Nobuyuki Horita, Katherine A. Webb, Naseh Sigari, Ioanna Tsiligianni, Natya Raghavan, Yoshitaka Ogata, William D.-C. Man, Afroditi K. Boutou, Cristina Martínez, Marc Miravitlles, Lowie E.G.W. Vanfleteren, Miriam T.J. Groenen, Barbora Novotna, Isabel Mir, Miguel Guimaraes, Alvar Agusti, Nart Bedin Atalay, Dionne E. Smid, Trevor Murrells, Stefanie Brighenti-Zogg, Henrik Watz, Seigo Minami, José Luis López-Campos, Frits M.E. Franssen, Nicholas S Hopkinson, Pilar de Lucas-Ramos, Emiel F.M. Wouters, James Piercy, Melissa Jehn, Emma Chaplin, Vladimir Koblizek, Ciro Casanova, Nikolaos Tzanakis, Rebecca Tanner, Hiroshi Kimura, Lana Maricic, Nienke Nakken, David Price, Alberto Fernández-Villar, Denis E. O'Donnell, Annika Karch, Martijn A. Spruit, Yu-Il Kim, Joan B. Soriano, Ines Ladeira, Yu Nishijima, Namhee Kwon, Victoria Higgins, Laura Mendoza, Eanes Delgado Barros Pereira, Julia L. Kelly, Thomas Ringbaek, Guogang G. Xie, Chaicharn Pothirat, James W. Dodd, Joerg D. Leuppi
Publikováno v:
Journal of the American Medical Directors Association, 18(12):ARTN 1097.e11-1097.e24. Elsevier Science
Journal of the American Medical Directors Association, 18(12), 1097.e11-1097.e24. ELSEVIER SCIENCE INC
Journal of the American Medical Directors Association, 18(12), 1097.e11-1097.e24. ELSEVIER SCIENCE INC
Background: Patients with chronic obstructive pulmonary disease (COPD) can be classified into groups A/C or B/D based on symptom intensity. Different threshold values for symptom questionnaires can result in misclassification and, in turn, different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::504d08bc67ca2698cc13fa7f78f8078e
https://aura.abdn.ac.uk/bitstream/2164/11472/1/SMID_ABCD_paper_JAMDA_published.pdf
https://aura.abdn.ac.uk/bitstream/2164/11472/1/SMID_ABCD_paper_JAMDA_published.pdf
Autor:
Seigo Minami, Kiyoshi Komuta, Takashi Sato, Moto Yaga, Shinji Futami, Naoki Matsushiro, Yu Nishijima, Yoshitaka Ogata, Suguru Yamamoto, Kentaro Masuhiro, Taro Koba
Publikováno v:
International Cancer Conference Journal. 4:13-17
A 79-year-old man presented with progressive right facial nerve palsy (FNP). He had pulmonary adenocarcinoma for 12 years and was treated with chemotherapy consisting of carboplatin plus paclitaxel. Neither an intracranial tumor nor cancer cells were
Autor:
Yoshitaka Ogata, Taro Koba, Masahiko Tsujimoto, Yu Nishijima, Ryu Jokoji, Shinji Futami, Seigo Minami, Kiyoshi Komuta, Suguru Yamamoto, Kentaro Masuhiro, Moto Yaga
Publikováno v:
World Journal of Oncology
A 60-year-old woman was diagnosed with metastatic pulmonary adenocarcinoma (c-stage IV) with an L858R point mutation in the gene encoding epidermal growth factor receptor (EGFR). Serum amylase levels were elevated (1,531 IU/L) with the salivary-type
Autor:
Shinji Futami, Masanari Hamaguchi, Tomoko Okazaki, Kiyoshi Komuta, Yoshitaka Ogata, Taro Koba, Kentaro Masuhiro, Seigo Minami, Shyouichi Shiraishi, Yu Nishijima, Suguru Yamamoto, Moto Yaga
Publikováno v:
International Cancer Conference Journal. 3:247-251
A 72-year-old Japanese man with locally advanced small-cell lung cancer presented with gait disturbance, caused by weakness in both lower extremities; this occurred during chemotherapy that effectively reduced the size of his tumor. Muscle weakness w
Autor:
Hiroshi Kida, Aiko Himeno, Yasushi Otani, Takashi Kijima, Kouji Inoue, Isao Tachibana, Yoshito Takeda, Masanori Matsumoto, Haruhiko Hirata, Yoshihiro Fujimura, Izumi Nagatomo, Atsushi Kumanogoh, Ryo Takahashi, Yu Nishijima
Publikováno v:
Internal Medicine. 52:1111-1114
A 61-year-old woman with recurrent non-small cell lung cancer presented with thrombocytopenia, microangiopathic hemolytic anemia, neurological abnormalities, renal failure and a fever that appeared during chemotherapy with gemcitabine and bevacizumab